Systolic heart failure
Disease1 paper1 finding
- Humans1
Associations
1Tirzepatide
downin humans1HR 0.8
1 study
Tirzepatide
downin humans1HR 0.8
Tirzepatide lowers the risk of systolic heart failure in humans (HR 0.8, 95% CI 0.79─0.92).
Humanscompared to semaglutide in patients with obesityone-yearn = 424,269
New-Onset Heart Failure in Patients with Obesity using Tirzepatide or Semaglutide · medRxiv · 26 Sep 2026 · Preprint
Latest
1medRxivHumansPreprint